These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

150 related items for PubMed ID: 21623090

  • 1. Detection of HIV drug resistance mutations in pregnant women receiving single dose Nevirapine in south India.
    Jacob MS, Durairaj A, Vijayakumari J, Srijayanth P, Sivakumar MR.
    Indian J Pathol Microbiol; 2011; 54(2):359-61. PubMed ID: 21623090
    [Abstract] [Full Text] [Related]

  • 2. Nevirapine resistance viral mutations after repeat use of nevirapine for prevention of perinatal HIV transmission.
    Kuhn L, Sinkala M, Kankasa MP, Kasonde P, Thea DM, Aldrovandi GM.
    J Acquir Immune Defic Syndr; 2006 Jun; 42(2):260-2. PubMed ID: 16760802
    [No Abstract] [Full Text] [Related]

  • 3. Minor drug-resistant HIV type-1 variants in breast milk and plasma of HIV type-1-infected Ugandan women after nevirapine single-dose prophylaxis.
    Pilger D, Hauser A, Kuecherer C, Mugenyi K, Kabasinguzi R, Somogyi S, Harms G, Kunz A.
    Antivir Ther; 2011 Jun; 16(1):109-13. PubMed ID: 21311114
    [Abstract] [Full Text] [Related]

  • 4. HIV-1 drug resistance and mother-to-child transmission.
    Morris L, Pillay C, Gray G, McIntyre J.
    SADJ; 2001 Dec; 56(12):614-6. PubMed ID: 11887450
    [Abstract] [Full Text] [Related]

  • 5. Health minister ignites row over drugs for HIV mothers.
    Check E.
    Nature; 2004 Jul 22; 430(6998):389. PubMed ID: 15269730
    [No Abstract] [Full Text] [Related]

  • 6. Minority HIV-1 drug-resistant mutations and prevention of mother-to-child transmission: perspectives for resource-limited countries.
    Samuel R, Paredes R, Parboosing R, Moodley P, Gordon M.
    AIDS Rev; 2014 Jul 22; 16(4):187-98. PubMed ID: 25300623
    [Abstract] [Full Text] [Related]

  • 7. Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa.
    van Zyl GU, Claassen M, Engelbrecht S, Laten JD, Cotton MF, Theron GB, Preiser W.
    J Med Virol; 2008 Jun 22; 80(6):942-6. PubMed ID: 18428139
    [Abstract] [Full Text] [Related]

  • 8. Nevirapine-induced resistance is a problem.
    S Afr Med J; 2004 May 22; 94(5):338. PubMed ID: 15211947
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of nevirapine (NVP) resistance mutations and HIV type 1 subtype in women from Abidjan (Côte d'Ivoire) after NVP single-dose prophylaxis of HIV type 1 mother-to-child transmission.
    Toni TD, Masquelier B, Lazaro E, Dore-Mbami M, Ba-Gomis FO, Téa-Diop Y, Kouakou K, Diby J, Sia E, Soppi S, Essien S, Schrive MH, Pinson P, Chenal H, Fleury HJ.
    AIDS Res Hum Retroviruses; 2005 Dec 22; 21(12):1031-4. PubMed ID: 16379606
    [Abstract] [Full Text] [Related]

  • 10. Resistance mutations in HIV-1 infected pregnant women and their infants receiving antiretrovirals to prevent HIV-1 vertical transmission in China.
    Han J, Wang L, Jiang Y, Zhang Q, Fang L, Yao J, Wang Q.
    Int J STD AIDS; 2009 Apr 22; 20(4):249-54. PubMed ID: 19304969
    [Abstract] [Full Text] [Related]

  • 11. Transmission of human immunodeficiency virus type 1 nevirapine resistance mutation K103N from a treatment-naive mother to her child.
    Schmitz T, Kleinkauf N, Klempa B, Ringe H, Varnholt V, Grosch-Wörner I.
    Pediatr Infect Dis J; 2006 Mar 22; 25(3):275-6. PubMed ID: 16511398
    [Abstract] [Full Text] [Related]

  • 12. Tolerance and viral resistance after single-dose nevirapine with tenofovir and emtricitabine to prevent vertical transmission of HIV-1.
    TEmAA ANRS 12109 Study group, Arrivé E, Chaix ML, Nerrienet E, Blanche S, Rouzioux C, Coffie PA, Kruy Leang S, McIntyre J, Avit D, Srey VH, Gray G, N'Dri-Yoman T, Diallo A, Ekouévi DK, Dabis F.
    AIDS; 2009 Apr 27; 23(7):825-33. PubMed ID: 19307941
    [Abstract] [Full Text] [Related]

  • 13. Single-dose nevirapine to prevent mother-to-child transmission of HIV type 1: balancing the benefits and risks.
    Mellors JW, Chow JY.
    Clin Infect Dis; 2009 Feb 15; 48(4):473-5. PubMed ID: 19133800
    [No Abstract] [Full Text] [Related]

  • 14. Protease inhibitor-based antiretroviral prophylaxis during pregnancy and the development of drug resistance.
    Gingelmaier A, Eberle J, Kost BP, Bogner JR, Hofmann J, Weissenbacher T, Kästner R, Friese K, Weizsaecker K.
    Clin Infect Dis; 2010 Mar 15; 50(6):890-4. PubMed ID: 20166821
    [Abstract] [Full Text] [Related]

  • 15. Genetic linkage of nevirapine resistance mutations in HIV type 1 seven days after single-dose nevirapine.
    Jones D, Parkin N, Hudelson SE, Guay LA, Musoke P, Mmiro F, Jackson JB, Eshleman SH.
    AIDS Res Hum Retroviruses; 2005 Apr 15; 21(4):319-24. PubMed ID: 15943576
    [Abstract] [Full Text] [Related]

  • 16. Resistance to antiretrovirals in HIV-infected pregnant women.
    Weinberg A, Forster-Harwood J, McFarland EJ, Pappas J, Davies JK, Kinzie K, Barr EA, Paul SM, Salbenblatt CR, Soda E, Vazquez A, Levin MJ.
    J Clin Virol; 2009 May 15; 45(1):39-42. PubMed ID: 19329355
    [Abstract] [Full Text] [Related]

  • 17. Effective program against mother-to-child transmission of HIV at Saint Camille Medical Centre in Burkina Faso.
    Simpore J, Pietra V, Pignatelli S, Karou D, Nadembega WM, Ilboudo D, Ceccherini-Silberstein F, Ghilat-Avoid-Belem WN, Bellocchi MC, Saleri N, Sanou MJ, Ouedraogo CM, Nikiema JB, Colizzi V, Perno CP, Castelli F, Musumeci S.
    J Med Virol; 2007 Jul 15; 79(7):873-9. PubMed ID: 17516517
    [Abstract] [Full Text] [Related]

  • 18. Nevirapine concentration in cervicovaginal and oropharyngeal secretions after single-dose administration to the mother.
    Harms G, Kunz A, Karcher H, Mugenyi K, Kurowski M.
    Antivir Ther; 2005 Jul 15; 10(6):777. PubMed ID: 16218178
    [No Abstract] [Full Text] [Related]

  • 19. Emergence of drug-resistant HIV-1 after intrapartum administration of single-dose nevirapine is substantially underestimated.
    Johnson JA, Li JF, Morris L, Martinson N, Gray G, McIntyre J, Heneine W.
    J Infect Dis; 2005 Jul 01; 192(1):16-23. PubMed ID: 15942889
    [Abstract] [Full Text] [Related]

  • 20. Nevirapine may promote resistance.
    AIDS Patient Care STDS; 2004 Apr 01; 18(4):249-50. PubMed ID: 15154406
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.